S'abonner

Aerobic exercise training and general health status in ambulatory heart failure patients with a reduced ejection fraction—Findings from the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION)trial - 16/05/17

Doi : 10.1016/j.ahj.2016.12.017 
Andrew P. Ambrosy, MD a, b, Lukasz P. Cerbin, MD a, Adam D. DeVore, MD a, b, Stephen J. Greene, MD a, b, William E. Kraus, MD a, b, Christopher M. O'Connor, MD b, c, Ileana L. Piña, MD d, David J. Whellan, MD e, Daniel Wojdyla, MS b, Angie Wu, BS b, Robert J. Mentz, MD a, b,
a Duke University Medical Center, Durham, NC, USA 
b Duke Clinical Research Institute, Durham, NC, USA 
c Inova Heart and Vascular Institute, Falls Church, VA, USA 
d Albert Einstein College of Medicine, Bronx, NY, USA 
e Jefferson Medical College, Philadelphia, PA. USA 

Reprint requests: Robert J. Mentz, MD, Assistant Professor of Medicine, Director, Duke University Cooperative Cardiovascular Society, Advanced Heart Failure and Cardiac Transplantation, Duke University Medical Center, Duke Clinical Research Institute, Durham, NC 27710, United States.Duke University Cooperative Cardiovascular Society, Advanced Heart Failure and Cardiac Transplantation, Duke University Medical Center, Duke Clinical Research InstituteDurhamNC27710United States

Abstract

Background

Although aerobic exercise improves quality of life as assessed by a disease-specific instrument in ambulatory HF patients with a reduced ejection fraction (EF), the impact of an exercise intervention on general health status has not been previously reported.

Methods

A secondary analysis was performed of the HF-ACTION trial (ClinicalTrials.gov Number: NCT00047437), which enrolled 2331 medically stable outpatients with HF and an EF ≤35% and randomized them to aerobic exercise training, consisting of 36 supervised sessions followed by home-based training versus usual care for a median follow-up of 30 months. The EuroQOL 5-dimension questionnaire (EQ-5D) was administered to study participants at baseline, 3 months, and 12 months. EQ-5D includes functional dimensions (ie, mobility, self-care, usual activities, pain/discomfort, and anxiety/depression), which were mapped to corresponding utility scores (ie, 0=death and 1=perfect health), and a visual analogue scale (VAS) ranging from 0 (ie, “worst imaginable health state”) to 100 (ie, “best imaginable health state”).

Results

Study participants had a median (25th, 75th) age of 59 (51, 68) years and 71% were male. A history of ischemic heart disease was reported in 51% of participants and the EF was 25% (20%, 30%). Baseline VAS and mapped utility scores were 65±19 and 0.81±0.14. Exercise training led to an improvement in VAS score compared with usual care from baseline to 3 months (exercise training: 6±17 vs usual care: 3±20; P <.01) although there were no further significant changes at 12 months. Aerobic exercise training did not favorably change mapped utility scores over either timeframe. After multivariable adjustment, lower mapped utility (hazard ratio [HR] 1.19 per 0.1 decrease, 95% CI 1.09–1.29; P < .0001) and VAS scores (HR 1.05 per 10 point decrease, 95% CI 1.02–1.08; P < .01) at baseline were associated with increased risk of death or hospitalization.

Conclusion

Ambulatory HF patients with a reduced EF had impaired health status at baseline which was associated with increased morbidity and mortality, in part mitigated by a structured aerobic exercise regimen.

Le texte complet de cet article est disponible en PDF.

Plan


 Javed Butler, MD, MPH served as guest editor for this article.
 RCT# NCT00047437


© 2017  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 186

P. 130-138 - avril 2017 Retour au numéro
Article précédent Article précédent
  • Incomplete revascularization for percutaneous coronary interventions: Variation among operators, and association with operator and hospital characteristics
  • Edward L. Hannan, Ye Zhong, Alice K. Jacobs, Frederick S.K. Ling, Peter B. Berger, Gary Walford, Ferdinand J. Venditti, Spencer B. King
| Article suivant Article suivant
  • Bendopnea: The next prognostic marker of advanced heart failure?
  • Ramón Baeza-Trinidad, Jose Daniel Mosquera-Lozano

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.